Daclatasvir 60mg is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:

• Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.


There are no reviews yet.

Be the first to review “Buy MyDekla (DAKLINZA) Daclatasvir 60mg Online”

Your email address will not be published. Required fields are marked *